Literature DB >> 29353455

The Interplay Between Apolipoprotein E4 and the Autophagic-Endocytic-Lysosomal Axis.

E Schmukler1, D M Michaelson1, R Pinkas-Kramarski2.   

Abstract

Since its discovery as a genetic risk factor for Alzheimer's disease, the APOE4 allele has been linked to the majority of the pathological findings associated with the disease progression. These include abnormalities of the endocytic, autophagic, and lysosomal machineries, which begin at the most early stages of Alzheimer's disease development. Considering that these three vesicular systems share common features and, in fact, comprise an interconnected cargo-trafficking and degradation network, some of the effects of APOE4 are interrelated, while others are system-specific. In turn, APOE4-driven impairments of endocytosis, autophagy, and lysosomal activity influence various aspects of Alzheimer's disease pathology, ranging from Aβ generation and clearance to neuronal loss and cognitive deficits. This review discusses the detrimental effects of APOE4 on the endocytic-autophagic-lysosomal axis in the context of Alzheimer's disease, as well as the various mechanisms underlying them.

Entities:  

Keywords:  Alzheimer’s disease (AD); Amyloid β; Apolipoprotein E4 (apoE4); Autophagy; Endocytosis; Lysosomal degradation

Mesh:

Substances:

Year:  2018        PMID: 29353455     DOI: 10.1007/s12035-018-0892-4

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  92 in total

Review 1.  The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review.

Authors:  R A Nixon; A M Cataldo; P M Mathews
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

Review 2.  Clathrin-mediated endocytosis and Alzheimer's disease: an update.

Authors:  Fangbai Wu; Pamela J Yao
Journal:  Ageing Res Rev       Date:  2009-03-21       Impact factor: 10.895

3.  Aborted autophagy and nonapoptotic death induced by farnesyl transferase inhibitor and lovastatin.

Authors:  Jonathan W Wojtkowiak; Komal M Sane; Miriam Kleinman; Bonnie F Sloane; John J Reiners; Raymond R Mattingly
Journal:  J Pharmacol Exp Ther       Date:  2011-01-12       Impact factor: 4.030

4.  Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins.

Authors:  A Steinmetz; C Jakobs; S Motzny; H Kaffarnik
Journal:  Arteriosclerosis       Date:  1989 May-Jun

5.  Reduction of synaptojanin 1 accelerates Aβ clearance and attenuates cognitive deterioration in an Alzheimer mouse model.

Authors:  Li Zhu; Minghao Zhong; Jiaying Zhao; Hannah Rhee; Ina Caesar; Elysse M Knight; Laura Volpicelli-Daley; Victor Bustos; William Netzer; Lijuan Liu; Louise Lucast; Michelle E Ehrlich; Nikolaos K Robakis; Samuel E Gandy; Dongming Cai
Journal:  J Biol Chem       Date:  2013-09-19       Impact factor: 5.157

Review 6.  Autophagy in aging and Alzheimer's disease: pathologic or protective?

Authors:  Aaron Barnett; Gregory J Brewer
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 7.  Apolipoprotein e sets the stage: response to injury triggers neuropathology.

Authors:  Robert W Mahley; Yadong Huang
Journal:  Neuron       Date:  2012-12-06       Impact factor: 17.173

Review 8.  HSV-1 and Alzheimer's disease: more than a hypothesis.

Authors:  Roberto Piacentini; Giovanna De Chiara; Domenica D Li Puma; Cristian Ripoli; Maria E Marcocci; Enrico Garaci; Anna T Palamara; Claudio Grassi
Journal:  Front Pharmacol       Date:  2014-05-07       Impact factor: 5.810

9.  Regulation of autophagy by kinases.

Authors:  Savitha Sridharan; Kirti Jain; Alakananda Basu
Journal:  Cancers (Basel)       Date:  2011-06-09       Impact factor: 6.639

Review 10.  Mechanisms of Aβ Clearance and Degradation by Glial Cells.

Authors:  Miriam Ries; Magdalena Sastre
Journal:  Front Aging Neurosci       Date:  2016-07-05       Impact factor: 5.750

View more
  10 in total

1.  Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH.

Authors:  Hari Prasad; Rajini Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-26       Impact factor: 11.205

2.  The Effects of APOE4 on Mitochondrial Dynamics and Proteins in vivo.

Authors:  Shira Simonovitch; Eran Schmukler; Eliezer Masliah; Ronit Pinkas-Kramarski; Daniel M Michaelson
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 3.  APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.

Authors:  Rosalía Fernández-Calle; Sabine C Konings; Javier Frontiñán-Rubio; Juan García-Revilla; Lluís Camprubí-Ferrer; Martina Svensson; Isak Martinson; Antonio Boza-Serrano; José Luís Venero; Henrietta M Nielsen; Gunnar K Gouras; Tomas Deierborg
Journal:  Mol Neurodegener       Date:  2022-09-24       Impact factor: 18.879

4.  Chronic Ethanol Causes Persistent Increases in Alzheimer's Tau Pathology in Female 3xTg-AD Mice: A Potential Role for Lysosomal Impairment.

Authors:  Autumn E Tucker; Coral Del Mar Alicea Pauneto; Alexandra M Barnett; Leon G Coleman
Journal:  Front Behav Neurosci       Date:  2022-05-11       Impact factor: 3.617

Review 5.  Cholesterol signaling in single cells: lessons from STAR and sm-FISH.

Authors:  Colin R Jefcoate; Jinwoo Lee
Journal:  J Mol Endocrinol       Date:  2018-05       Impact factor: 5.098

6.  Retinal imaging demonstrates reduced capillary density in clinically unimpaired APOE ε4 gene carriers.

Authors:  Fanny M Elahi; Senyo B Ashimatey; Daniel J Bennett; Samantha M Walters; Renaud La Joie; Xuejuan Jiang; Amy Wolf; Yann Cobigo; Adam M Staffaroni; Howie J Rosen; Bruce L Miller; Gil D Rabinovici; Joel H Kramer; Ari J Green; Amir H Kashani
Journal:  Alzheimers Dement (Amst)       Date:  2021-05-11

7.  Altered mitochondrial dynamics and function in APOE4-expressing astrocytes.

Authors:  Eran Schmukler; Shira Solomon; Shira Simonovitch; Yona Goldshmit; Eya Wolfson; Daniel Morris Michaelson; Ronit Pinkas-Kramarski
Journal:  Cell Death Dis       Date:  2020-07-24       Impact factor: 8.469

8.  Amyloid-beta impairs TOM1-mediated IL-1R1 signaling.

Authors:  Alessandra Cadete Martini; Angela Gomez-Arboledas; Stefania Forner; Carlos J Rodriguez-Ortiz; Amanda McQuade; Emma Danhash; Jimmy Phan; Dominic Javonillo; Jordan-Vu Ha; Melanie Tram; Laura Trujillo-Estrada; Celia da Cunha; Rahasson R Ager; Jose C Davila; Masashi Kitazawa; Mathew Blurton-Jones; Antonia Gutierrez; David Baglietto-Vargas; Rodrigo Medeiros; Frank M LaFerla
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-30       Impact factor: 11.205

9.  A logical network-based drug-screening platform for Alzheimer's disease representing pathological features of human brain organoids.

Authors:  Jong-Chan Park; So-Yeong Jang; Dongjoon Lee; Jeongha Lee; Uiryong Kang; Hongjun Chang; Haeng Jun Kim; Sun-Ho Han; Jinsoo Seo; Murim Choi; Dong Young Lee; Min Soo Byun; Dahyun Yi; Kwang-Hyun Cho; Inhee Mook-Jung
Journal:  Nat Commun       Date:  2021-01-12       Impact factor: 14.919

10.  The Value of Brain Structural Magnetic Resonance Imaging Combined with APOE--ε4 Genotype in Early Diagnosis and Disease Progression of Senile Vascular Cognitive Impairment No Dementia.

Authors:  Weina Zhao; Changhao Yin; Fengbo Yu; Lifei Wan; Siyao Che; Lili Cui
Journal:  Contrast Media Mol Imaging       Date:  2022-03-05       Impact factor: 3.009

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.